X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - WN.COM - Health - 20/Jan 22:52

Immune‑Driven Vaccine Advances Cancer Prevention Research

The results of a Phase Ib/II clinical trial, published today in Nature Medicine, provide early evidence that immune-based approaches, such as NOUS-209, may be able to intercept cancer before it develops, offering a potential new avenue for preventive care for high-risk individuals. Image for illustration purposes Mega Doctor News MD Anderson Research News HOUSTON – The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University...

Articles similaires

Sorry! Image not available at this time

Immune‑Driven Vaccine Advances Cancer Prevention Research

wn.com - 20/Jan 22:52

The results of a Phase Ib/II clinical trial, published today in Nature Medicine, provide early evidence that immune-based approaches, such as...

Sorry! Image not available at this time

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

oncologynews.com.au - 25/Jan 04:14

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in...

Sorry! Image not available at this time

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

oncologynews.com.au - 25/Jan 04:14

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in...

Sorry! Image not available at this time

Researchers discover a mechanism that allows melanoma cancer cells to paralyse immune cells

oncologynews.com.au - 23/Jan 05:59

A new international study led by the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds melanoma cancer cells paralyse immune...

Sorry! Image not available at this time

Researchers discover a mechanism that allows melanoma cancer cells to paralyse immune cells

oncologynews.com.au - 23/Jan 05:59

A new international study led by the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds melanoma cancer cells paralyse immune...

Sorry! Image not available at this time

Inhalable therapy aims for one-two punch against advanced melanoma

oncologynews.com.au - 23/Jan 06:13

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the body’s own cells. Cancer...

Sorry! Image not available at this time

Inhalable therapy aims for one-two punch against advanced melanoma

oncologynews.com.au - 23/Jan 06:13

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the body’s own cells. Cancer...

Sorry! Image not available at this time

Nanotechnology may be used in targeting tumors, Brown study finds

wn.com - 23/Jan 19:07

In a recent study about enhancing the precision of a therapeutic drug to target tumors, the Desai Lab — led by principal investigator and Dean of...

Sorry! Image not available at this time

Nanotechnology may be used in targeting tumors, Brown study finds

wn.com - 23/Jan 19:07

In a recent study about enhancing the precision of a therapeutic drug to target tumors, the Desai Lab — led by principal investigator and Dean of...

Sorry! Image not available at this time

New research uncovers molecular ‘safety switch’ shielding cancers from immune attack

oncologynews.com.au - 23/Jan 16:31

Australian researchers have discovered that the TAK1 gene helps cancer cells survive immune system attacks, revealing a mechanism that may limit the...

Les derniers communiqués